-+ 0.00%
-+ 0.00%
-+ 0.00%

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Benzinga·07/25/2025 12:34:46
Listen to the news

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.

Shares of Intel Corporation (NASDAQ:INTC) fell in pre-market trading following second-quarter results.

Intel reported a loss for the second quarter, while sales topped estimates. Intel expects third-quarter revenue to be in the range of $12.6 billion to $13.6 billion, versus estimates of $12.63 billion. The company anticipates a third-quarter loss of 24 cents per share versus estimates for a loss of 18 cents per share. Intel CEO Lip-Bu Tan shared a memo with employees saying that the company will reduce its workforce to 75,000 employees by the end of the year through layoffs and attrition.

Intel shares dipped 5.9% to $21.30 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

  • Absci Corporation (NASDAQ:ABSI) declined 13.7% to $3.03 in pre-market trading after the company announced the pricing of public offering of common stock.
  • AST SpaceMobile, Inc. (NASDAQ:ASTS) fell 9.2% to $54.56 in pre-market trading after the company announced a $500 million private offering of convertible senior notes.
  • Almonty Industries Inc. (NASDAQ:ALM) dipped 8.5% to $4.06 in pre-market trading.
  • Synovus Financial Corp. (NYSE:SNV) fell 8.3% to $51.88 in pre-market trading. Pinnacle and Synovus announced an $8.6 billion all-stock merger.
  • Sarepta Therapeutics, Inc. (NASDAQ:SRPT) declined 5.2% to $12.20 in pre-market trading. Citigroup analyst Yigal Nochomovitz, on Thursday, initiated coverage on Sarepta Therapeutics with a Sell rating and announced a price target of $7.
  • ABIVAX Société Anonyme (NASDAQ:ABVX) fell 4% to $66.99 in pre-market trading. Abivax announced full exercise of underwriters’ option to purchase additional ADSs, bringing gross proceeds of offering to $747.5 million (€637.5 million).
  • Semler Scientific, Inc. (NASDAQ:SMLR) fell 3.6% to $37.50 in pre-market trading.

Now Read This:

Photo via Shutterstock